Clinical and experimental dermatology · 2026
Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Yen-Ning, Shen Chin-Hsuan, Tai Cheng-Chen, Wang Tzu-Yu, Chi Ching-Chi
Аннотация
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis primarily affecting women of reproductive age. HS may contribute to an increase of adverse pregnancy outcomes (APOs).
OBJECTIVES: To investigate the association of HS with APOs.
METHODS: A systematic review was conducted of observational studies examining the association of maternal HS with APOs. We searched MEDLINE, Embase and CENTRAL from inception to 15 March 2025 for relevant studies. No restrictions were imposed on language or geographical regions. Observational studies, including cohort and case-control designs, which examined the odds or risk of APOs among pregnant patients were considered eligible for inclusion. The risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model meta-analysis using the inverse-variance-weighted method was performed.
RESULTS: We included four retrospective cohort studies with 15 189 175 pregnancies. The overall risk of bias was low to unclear. The meta-analysis revealed associations of HS with APOs, including gestational diabetes mellitus [odds ratio (OR) 1.46, 95% confidence interval (CI) 1.09-1.96], pre-eclampsia/eclampsia (OR 1.18, 95% CI 1.01-1.38), caesarean section (OR 1.31, 95% CI 1.04-1.64) and postpartum haemorrhage (OR 1.39, 95% CI 1.07-1.82). Regarding adverse fetal outcomes, maternal HS was significantly associated with spontaneous abortion (OR 1.19, 95% CI 1.06-1.34), preterm birth (OR 1.17, 95% CI 1.04-1.31) and birth defects (OR 1.47, 95% CI 1.03-2.11).
CONCLUSIONS: Pregnant women with HS have an increased risk of APOs, underscoring the need for coordinated care between dermatologists and obstetricians, as well as early diagnosis and intervention to mitigate potential risks to maternal health and fetal development.
OBJECTIVES: To investigate the association of HS with APOs.
METHODS: A systematic review was conducted of observational studies examining the association of maternal HS with APOs. We searched MEDLINE, Embase and CENTRAL from inception to 15 March 2025 for relevant studies. No restrictions were imposed on language or geographical regions. Observational studies, including cohort and case-control designs, which examined the odds or risk of APOs among pregnant patients were considered eligible for inclusion. The risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model meta-analysis using the inverse-variance-weighted method was performed.
RESULTS: We included four retrospective cohort studies with 15 189 175 pregnancies. The overall risk of bias was low to unclear. The meta-analysis revealed associations of HS with APOs, including gestational diabetes mellitus [odds ratio (OR) 1.46, 95% confidence interval (CI) 1.09-1.96], pre-eclampsia/eclampsia (OR 1.18, 95% CI 1.01-1.38), caesarean section (OR 1.31, 95% CI 1.04-1.64) and postpartum haemorrhage (OR 1.39, 95% CI 1.07-1.82). Regarding adverse fetal outcomes, maternal HS was significantly associated with spontaneous abortion (OR 1.19, 95% CI 1.06-1.34), preterm birth (OR 1.17, 95% CI 1.04-1.31) and birth defects (OR 1.47, 95% CI 1.03-2.11).
CONCLUSIONS: Pregnant women with HS have an increased risk of APOs, underscoring the need for coordinated care between dermatologists and obstetricians, as well as early diagnosis and intervention to mitigate potential risks to maternal health and fetal development.